Filing Flows › Comparisons › MRK vs ABBV
Merck vs AbbVie: MRK and ABBV compared
Merck is the larger company: $18.1B of revenue in its latest quarter (Q3 2026) against $17.4B for AbbVie (Q3 2026). AbbVie is growing faster (+10% against +5% a year earlier). AbbVie is more profitable, with an operating margin of 36.0% against 30.7%.
Where the money goes: MRK and ABBV
Merck (MRK) · Q3 2026
Merck, Q3 2026: revenue $18.1B (+5% year over year), operating margin 30.7%, net earnings $5.1B, operating cash flow $6.6B. The chart follows the revenue to costs, profit and cash.
AbbVie (ABBV) · Q3 2026
AbbVie, Q3 2026: revenue $17.4B (+10% year over year), operating margin 36.0%, net earnings $4.2B, operating cash flow $7.6B. The chart follows the revenue to costs, profit and cash.
| Merck (MRK) | AbbVie (ABBV) | |
|---|---|---|
| Latest quarter | Q3 2026 | Q3 2026 |
| Revenue | $18.1B | $17.4B |
| Revenue growth, Y/Y | +5% | +10% |
| Operating margin | 30.7% | 36.0% |
| Net earnings | $5.1B | $4.2B |
| Net margin | 28.0% | 24.2% |
| Operating cash flow | $6.6B | $7.6B |
| Free cash flow | $5.5B | $7.3B |
| Market value | $363.6B | $516.2B |
| P/E | 151.3× | 50.1× |
| Analysts’ mean target | $161.53 | $310.65 |
Questions
Which is bigger, Merck or AbbVie?
Merck is the larger company: $18.1B of revenue in its latest quarter (Q3 2026) against $17.4B for AbbVie (Q3 2026).
Is Merck or AbbVie growing faster?
AbbVie is growing faster (+10% against +5% a year earlier).
Which is more profitable, Merck or AbbVie?
AbbVie is more profitable, with an operating margin of 36.0% against 30.7%.
More: Merck earnings · how Merck makes money · AbbVie earnings · how AbbVie makes money
From the companies' latest 10-Q, 10-K or earnings release (10-Q filed Nov 4, 2026; 10-Q filed Nov 3, 2026). Fiscal quarters can end on different dates. Not investment advice.